Single-cell transcriptome sequencing reveals potential novel combination of biomarkers for antibody-based cancer therapeutics in hepatocellular carcinoma.

Tang, Hong; Yuan, Jun; Gong, Yuan-Feng; Zhang, Cheng-Yang; Liu, Ming; Luo, Su-Xia

Tang, Hong; Yuan, Jun; Gong, Yuan-Feng; Zhang, Cheng-Yang; Liu, Ming; Luo, Su-Xia.

Afiliação

Tang H; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Yuan J; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Gong YF; School of Basic Medical Science, Guangzhou Medical University, Guangzhou, China.
Zhang CY; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Liu M; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Luo SX; School of Basic Medical Science, Guangzhou Medical University, Guangzhou, China.

Front Genet ; 13: 928256, 2022.

Article em En | MEDLINE | ID: mdl-36186483

Palavras-chave

antibody drug; cancer immune-therapeutics; hepatocellular carcinoma; plasma membrane protein; precision medicine; single-cell RNA sequencing; therapeutic resistance; tumor heterogeneity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article